(2026). Retraction: Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations. PLoS ONE. https://doi.org/10.1371/journal.pone.0348537